Ascorbic acid treatment corrects the phenotype of a mouse model of Charcot-Marie-Tooth disease. - Wikidata - awgldk - TriplyDB

Ascorbic acid treatment corrects the phenotype of a mouse model of Charcot-Marie-Tooth disease.

Ascorbic acid treatment corrects the phenotype of a mouse model of Charcot-Marie-Tooth disease.

http://www.wikidata.org/entity/Q33976802

about

Antiproliferative effect of ascorbic acid is associated with the inhibition of genes necessary to cell cycle progression Genomic disorders: molecular mechanisms for rearrangements and conveyed phenotypes An exploratory randomised double-blind and placebo-controlled phase 2 study of a combination of baclofen, naltrexone and sorbitol (PXT3003) in patients with Charcot-Marie-Tooth disease type 1A Ascorbic acid for the treatment of Charcot-Marie-Tooth disease Treatment for Charcot-Marie-Tooth disease Vitamin C: update on physiology and pharmacology Management of Charcot-Marie-Tooth disease: improving long-term care with a multidisciplinary approach The genetics of Charcot-Marie-Tooth disease: current trends and future implications for diagnosis and management Charcot-Marie-Tooth disease and intracellular traffic Regulation of the Epigenome by Vitamin C Transcriptome Analysis of Ullrich Congenital Muscular Dystrophy Fibroblasts Reveals a Disease Extracellular Matrix Signature and Key Molecular Regulators Haplotype-specific modulation of a SOX10/CREB response element at the Charcot-Marie-Tooth disease type 4C locus SH3TC2.Hypergonadotropic hypogonadism, progressive early-onset spinocerebellar ataxia, and late-onset sensorineural hearing loss: case report and literature review.Functional and comparative genomics analyses of pmp22 in medaka fish Oral high dose ascorbic acid treatment for one year in young CMT1A patients: a randomised, double-blind, placebo-controlled phase II trial Determinants of reduced health-related quality of life in pediatric inherited neuropathies.The PMP22 gene and its related diseases.Ascorbic acid is a dose-dependent inhibitor of adipocyte differentiation, probably by reducing cAMP pool.Genome editing-enabled HTS assays expand drug target pathways for Charcot-Marie-tooth disease.Axonal Charcot-Marie-Tooth disease patient-derived motor neurons demonstrate disease-specific phenotypes including abnormal electrophysiological properties.Antioxidants reduce cone cell death in a model of retinitis pigmentosa Regulation of the PMP22 gene through an intronic enhancer.Pharmacological induction of the heat shock response improves myelination in a neuropathic model Ascorbic acid in Charcot-Marie-Tooth disease type 1A (CMT-TRIAAL and CMT-TRAUK): a double-blind randomised trial.Overexpression of mutant HSP27 causes axonal neuropathy in mice.Distal enhancers upstream of the Charcot-Marie-Tooth type 1A disease gene PMP22 Oral curcumin mitigates the clinical and neuropathologic phenotype of the Trembler-J mouse: a potential therapy for inherited neuropathy Rare structural variants in schizophrenia: one disorder, multiple mutations; one mutation, multiple disorders Identification of drug modulators targeting gene-dosage disease CMT1A.Neurology and orthopaedics Plasma metabolome and skin proteins in Charcot-Marie-Tooth 1A patients Molecular genetics of autosomal-dominant demyelinating Charcot-Marie-Tooth disease.Autosomal-recessive forms of demyelinating Charcot-Marie-Tooth disease.Animal models of Charcot-Marie-Tooth disease type 1A.Pathomechanisms of mutant proteins in Charcot-Marie-Tooth disease.Molecular diagnostics of Charcot-Marie-Tooth disease and related peripheral neuropathies.Vitamin C and Charcot-Marie-Tooth 1A: Pharmacokinetic considerations.Inherited peripheral neuropathies.Update on Charcot-Marie-Tooth disease.Molecular mechanisms of inherited demyelinating neuropathies.

P2860

Q21143876-30EC11A3-BE56-4698-867D-CCE9B4CDE8FE Q21145278-FF45A859-950F-4EAF-B841-9C7352182E0F Q22000603-558BA71F-CA85-4A78-A059-4698A31B3169 Q24187132-BD4F782E-46C3-42C8-9015-BBA60BEE8DF3 Q24242777-E60DA707-BE84-40F5-8F94-270BA6076494 Q24654791-85C78D2D-947A-4D75-BA04-95E111B4B528 Q26768401-3DB158E5-6D3A-4E98-A9A8-B9F77C102EEF Q26777319-44242DFB-70B6-4B49-8694-089C589D7759 Q26824841-EF81DB6D-FE3F-4466-8CDC-C0D14B67A8A4 Q27000867-3A3188EE-FF68-4673-A42B-8B9B98A4A6B3 Q28271052-3CD830D3-6571-40DD-B39D-E70F9DB6CB4B Q30009423-97D5D22A-3551-469D-9212-3146F0988B83 Q30449162-4DAA5A0B-3B18-452D-B3CC-036DF6216D69 Q30488983-41453B77-16CC-4326-B4E6-987167E8D3B7 Q30883545-030336D1-810B-4DD6-A867-77E7A9CE03C5 Q34098654-7827C044-435B-4B50-917B-A49AD3E5CE82 Q34316615-25CD53B8-CD84-4609-A165-5986956C56EB Q34391349-56A96D99-84A4-49F8-AF48-BEDF3BA6B44D Q34576213-9BD33F43-41B5-44F2-9CF1-1EE120D5440A Q34674307-EABB3726-4F71-4322-BBF6-30B924A18C36 Q34983972-81AC0055-1F1F-49C4-A1B2-BFFEF6871AFF Q35001004-B0E78641-FA07-4BA7-AF9E-1B539D7B3770 Q35060096-DDF2F62C-F91C-44E2-855E-41A1981793D2 Q35159258-6CFFE5E8-2D44-462E-BE38-EB7D28F99C7D Q35814416-6C25A80B-425D-4FBD-97C0-1B0928E921EA Q35817491-216FD8DA-3142-4BAA-A0C2-96443644F35D Q35946355-A76886F0-397E-4B4A-A78F-FFA395736796 Q35956872-00459AF5-3A01-40E2-BE68-934D40A5F68D Q36106700-78EB4AB6-7B0C-47D8-B0C3-DA10C8CC5632 Q36226880-74537A23-E438-4D47-8B43-AB0F1D5A96D1 Q36390813-5BDBB9D8-D5B6-42FC-9B6F-B00E4B1F1ADD Q36507140-740B6922-6461-4FB6-8468-AC5B9C3E33AF Q36507147-A9870BD6-297F-424F-B189-BBFB584B8E52 Q36507179-E84DD56D-FF1F-48CC-82A0-78054EBAE2F0 Q36507183-F7FCB629-0A7E-48DD-9A01-33CD5BB10637 Q36507186-0C41C728-FA26-4B04-ACA5-CE4AB9F29163 Q36701520-89B96702-A734-425B-BC57-E38586EEF54B Q36822088-2EF3E98A-4234-4F64-AEE5-FE0CAF121498 Q36937164-6AA58035-C498-4258-95A8-04E077FB9F79 Q36942808-0645FB52-B7F6-4951-B233-CA295DAAC8D3

P2860

Ascorbic acid treatment corrects the phenotype of a mouse model of Charcot-Marie-Tooth disease.

http://www.wikidata.org/entity/Q33976802

description

2004 nî lūn-bûn

@nan

2004 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի մարտին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

name

Ascorbic acid treatment correc ...... f Charcot-Marie-Tooth disease.

@ast

Ascorbic acid treatment correc ...... f Charcot-Marie-Tooth disease.

@en

type

label

Ascorbic acid treatment correc ...... f Charcot-Marie-Tooth disease.

@ast

Ascorbic acid treatment correc ...... f Charcot-Marie-Tooth disease.

@en

prefLabel

Ascorbic acid treatment correc ...... f Charcot-Marie-Tooth disease.

@ast

Ascorbic acid treatment correc ...... f Charcot-Marie-Tooth disease.

@en

P1433

Q33976802-841814C9-BF5A-44CF-B450-1264AA5F2966

P1476

Q33976802-0C5A4EEF-31F4-437E-9125-697F65BE74B1

P2093

Q33976802-084DA7CB-B18A-4B9A-89D5-E361E20269AE

Q33976802-186B9A92-BBAC-45CB-B124-4BF7A5CF0771

Q33976802-32D7DD5C-7D0D-4C0C-A879-F57669DFA7F3

Q33976802-9F43AE26-EBA8-4C30-9416-7CD631571784

Q33976802-A2353BD7-E96D-4C52-B5A5-11F83721212C

Q33976802-AC2C9E57-6451-4554-A484-B4EE98C8EDBF

Q33976802-BAB852DD-9F55-4193-986A-9EF1D045A9E0

Q33976802-CC0FBFE2-331B-4C61-8A72-717150882D45

Q33976802-F712F99A-560B-41EE-86E7-3528655D7E20

P2888

Q33976802-5BDDB671-0214-461E-B4D6-74C54A7CEF04

P304

Q33976802-C0E8B7B4-66C9-4B87-AA5F-CEE6A1D6BEDF

P31

Q33976802-1365E0A7-1B82-45DE-B37B-2BC712094E60

P356

Q33976802-B935CF36-5685-43CA-AA98-B7CA311FBDB8

P407

Q33976802-29CEAC78-856E-44C8-9678-B62C343C9C4D

P433

Q33976802-6384ECEA-AFE2-4901-9AF7-7A654446DF04

P478

Q33976802-A747C983-FBAD-49ED-B295-9C75419B52A6

P577

Q33976802-7EAEC046-412E-4FB0-9557-CB528A5CD8AD

P5875

Q33976802-D6FAD222-353E-4D31-9A3E-8AC8D64BDDCC

P6179

Q33976802-CFDF1F2C-C58E-4882-BA0E-B52A9760F8B3

P698

Q33976802-D7AC882D-97B0-4CA8-8576-5BAD34AB7B98

P356

P1433

Nature Medicine

P1476

Ascorbic acid treatment correc ...... f Charcot-Marie-Tooth disease.

@en

P2093

Andrée Robaglia-Schlupp

http://www.w3.org/2001/XMLSchema#string

Edith Passage

http://www.w3.org/2001/XMLSchema#string

Jean Chrétien Norreel

http://www.w3.org/2001/XMLSchema#string

Jean François Pellissier

http://www.w3.org/2001/XMLSchema#string

Josette Pizant

http://www.w3.org/2001/XMLSchema#string

Michel Fontés

http://www.w3.org/2001/XMLSchema#string

Pauline Noack-Fraissignes

http://www.w3.org/2001/XMLSchema#string

Véronique Sanguedolce

http://www.w3.org/2001/XMLSchema#string

Xavier Thirion

http://www.w3.org/2001/XMLSchema#string

P2888

P304

396-401

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NM1023

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P577

2004-03-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8666165

http://www.w3.org/2001/XMLSchema#string

P6179

1042941247

http://www.w3.org/2001/XMLSchema#string

P698

15034573

http://www.w3.org/2001/XMLSchema#string